EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathwayMeng-Feng Tsai, Jin‐Yuan Shih|Scientific Reports|2015Cited by 69
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancerYi‐Nan Liu, Jin‐Yuan Shih|International Journal of Cancer|2019Cited by 61
Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response PredictionShang‐Gin Wu, Jin‐Yuan Shih|PLoS ONE|2011Cited by 49
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung CancerChien‐Hung Gow, Jin‐Yuan Shih|Neoplasia|2018Cited by 40
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44Shang‐Gin Wu, Jin‐Yuan Shih|Molecular Therapy — Nucleic Acids|2023Cited by 18